All In Biotech

Drug Trial Radar · NCT07885852

Cold Water Papillary Irrigation Plus Rectal NSAIDs vs Rectal NSAIDs Alone for Post-ERCP Pancreatitis (COLD)

Prevention of Post-ERCP Pancreatitis With Cold Water Irrigation of the Papilla Added to Rectal NSAIDs Versus Rectal NSAIDs Alone: a Single-Center, Randomized, Single-Blind Pilot Trial

Last checked: Nov 20, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Nov 1, 2026

Primary completion

Dec 31, 2027

Study completion Jun 30, 2028

Sponsor

Lead sponsor
University Hospital Virgen de las NievesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 21, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Post-ERCP pancreatitis is the most frequent complication of endoscopic retrograde cholangiopancreatography (ERCP). Rectal non-steroidal anti-inflammatory drugs (NSAIDs) are the current standard prophylaxis. Recent studies suggest that irrigating the papilla with cold water after biliary sphincterotomy may reduce the risk of pancreatitis, but this has not been tested in combination with rectal NSAIDs. This pilot randomized trial compares rectal NSAIDs plus cold water irrigation of the papilla with rectal NSAIDs alone in adults undergoing ERCP with sphincterotomy. Patients are unaware of their group. The main outcome is the incidence of post-ERCP pancreatitis. Results will be used to estimate event rates and calculate the sample size of a future confirmatory trial. Unlike previous trials, prophylaxis consists of rectal diclofenac without aggressive intravenous hydration, reflecting standard European practice.

Conditions

  • Post ERCP Pancreatitis
  • Acute Pancreatitis (AP)

Interventions

  • Cold water irrigation of the papillaProcedure

    250 mL of ice-cold water (5 × 50 mL) instilled through the duodenoscope working channel after sphincterotomy; the first four aliquots are aspirated

  • Rectal NSAID (diclofenac 100 mg)Drug

    Standard pre-procedural prophylaxis administered to all patients

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of post-ERCP pancreatitis (Cotton criteria)Time frame: Day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Gastroenterology and Hepatology. Virgen de las Nieves University Hospitals

    Granada, Granada, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.